Pharma stocks rise 10% within 6 months of stable FDA leadership

Pharma stocks will increase by at least 10% within 6 months of the FDA commissioner serving a full term, as regulatory consistency boosts investor confidence and accelerates drug approvals.

Implied probability (Yes)

60%